Detalhe da pesquisa
1.
A Highly Durable RNAi Therapeutic Inhibitor of PCSK9.
N Engl J Med
; 376(1): 41-51, 2017 01 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27959715
2.
Phase 2b Study of Pimodivir (JNJ-63623872) as Monotherapy or in Combination With Oseltamivir for Treatment of Acute Uncomplicated Seasonal Influenza A: TOPAZ Trial.
J Infect Dis
; 219(7): 1026-1034, 2019 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30428049
3.
Response-guided telaprevir combination treatment for hepatitis C virus infection.
N Engl J Med
; 365(11): 1014-24, 2011 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21916639
4.
Telaprevir for previously untreated chronic hepatitis C virus infection.
N Engl J Med
; 364(25): 2405-16, 2011 Jun 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-21696307
5.
Telaprevir for previously treated chronic HCV infection.
N Engl J Med
; 362(14): 1292-303, 2010 Apr 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-20375406
6.
Futility rules for telaprevir combination treatment for patients with hepatitis C virus infection.
Clin Gastroenterol Hepatol
; 11(2): 193-5, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23159528
7.
A viral dynamic model for treatment regimens with direct-acting antivirals for chronic hepatitis C infection.
PLoS Comput Biol
; 8(1): e1002339, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22241977
8.
Telaprevir and peginterferon with or without ribavirin for chronic HCV infection.
N Engl J Med
; 360(18): 1839-50, 2009 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-19403903
9.
Retreatment with telaprevir combination therapy in hepatitis C patients with well-characterized prior treatment response.
Hepatology
; 54(5): 1538-46, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22045671
10.
Patterns of viral load decline with telaprevir-based therapy in patients with genotype 1 chronic HCV infection.
J Clin Virol
; 59(3): 148-55, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24462470
11.
Review of drug interactions with telaprevir and antiretrovirals.
Antivir Ther
; 18(4): 553-60, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23344266
12.
Telaprevir-related dermatitis.
JAMA Dermatol
; 149(2): 152-8, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23560295
13.
Telaprevir: pharmacokinetics and drug interactions.
Antivir Ther
; 17(7): 1211-21, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22954756
14.
Hepatitis C viral evolution in genotype 1 treatment-naïve and treatment-experienced patients receiving telaprevir-based therapy in clinical trials.
PLoS One
; 7(4): e34372, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22511937
15.
Discovery and development of telaprevir: an NS3-4A protease inhibitor for treating genotype 1 chronic hepatitis C virus.
Nat Biotechnol
; 29(11): 993-1003, 2011 Nov 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-22068541
16.
Efficacy, pharmacodynamics, and safety of VX-702, a novel p38 MAPK inhibitor, in rheumatoid arthritis: results of two randomized, double-blind, placebo-controlled clinical studies.
Arthritis Rheum
; 60(5): 1232-41, 2009 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-19404957